SCNI

Scinai Immunotherapeutics Ltd.

0.97

0.14+16.63%

Opening13:35 01/14 EST

Daily

Weekly

Monthly

Quarterly

Yearly

OPEN/PREV CLOSE0.8877/0.8300

TODAY RANGE0.8789-0.9690

VOL80.44K

MARKET CAP3.36M

52 WEEK RANGE0.6130-6.18

AVG VOL (3M)56.55K

% TURNOVER2.32%

TURNOVER--

P/E (TTM)0.1212

% RANGE10.86%

EPS(TTM)7.99

P/E(FORWARD)-0.4840

P/B0.1866

BVPS5.19

DIVIDEND--

P/S1.254

BETA--

DIV YIELD0.00%

FREE FLOAT MKT CAP3.01M

SHARES OUTSTANDING3.47M

NEXT EARNINGS--

FREE FLOAT3.11M

LOT SIZE1

EX-DATE05/21/2024

News

Press Releases

Financial Reports

Profile

PR Newswire·01/07 12:00
Scinai CEO Amir Reichman to Co-Lead Manufacturers Association Biopharma Manufacturing Roundtable at HealthIL
TipRanks·12/23/2025 21:30
Scinai Immunotherapeutics Shareholders Approve Share Increase, Equity Grants and Auditor at December 22 Meeting
TipRanks·12/03/2025 03:52
Scinai Immunotherapeutics Reports Growth and Pipeline Progress
TipRanks·12/02/2025 16:27
Scinai Immunotherapeutics Reports Nine-Month 2025 Results and Strategic Developments
PR Newswire·12/02/2025 13:50
Scinai Reports Nine-Month 2025 Results as CDMO Growth Continues and NanoAbs Pipeline Advances
TipRanks·11/13/2025 22:41
Scinai Immunotherapeutics Announces December 2025 Shareholder Meeting
TipRanks·11/13/2025 22:26
Scinai Immunotherapeutics Announces Board Changes and New Accounting Firm Amid Cost-Cutting Efforts
TipRanks·10/06/2025 12:20
Scinai Immunotherapeutics Secures Grant to Boost CDMO Capabilities
TipRanks·10/06/2025 11:40
Scinai Immunotherapeutics awarded grant from Israel Innovation Authority
PR Newswire·10/06/2025 11:30
Scinai Awarded Israel Innovation Authority Grant to Expand Fill-and-Finish CDMO Capabilities
TipRanks·09/22/2025 12:47
Scinai Immunotherapeutics to Appeal Rejected Grant for PC111 Development
TipRanks·09/11/2025 12:14
Scinai Immunotherapeutics Secures $15 Million Equity Purchase Agreement
TipRanks·09/02/2025 20:49
Scinai Immunotherapeutics Reports Strong CDMO Growth and Financial Results for H1 2025
Seeking Alpha·09/02/2025 12:58
Scinai Immunotherapeutics reports 1H results
TipRanks·07/29/2025 11:31
Scinai Immunotherapeutics’ PC111 featured in peer-reviewed publication

Same Industry

Name/Symbol

Change%

Price

Scinai Immunotherapeutics Ltd.

SCNI

+16.75%

0.9690

Regeneron Pharmaceuticals

REGN

-0.39%

755.98

GridAI Tech

GRDX

0.00%

3.95

BIONTECH

BNTX

+1.31%

108.59

United Therapeutics Corp.

UTHR

-0.92%

472.48

Vertex Pharmaceuticals Inc

VRTX

-1.50%

447.87

Siga Technologie

SIGA

+1.97%

6.73

Moderna

MRNA

+2.65%

40.65

Charles Riv Labs Intl Inc

CRL

-0.93%

216.95

Medpace Holdings

MEDP

+0.23%

609.82

Talphera Inc

TLPH

+2.43%

1.06

ICON PLC

ICLR

+1.18%

185.45

China Biologic

CBPO

0.00%

119.99

Iqvia Hldgs Inc

IQV

-0.06%

241.43

MOLECULAR PARTNERS AG

MOLN

-0.48%

4.11

PRA Health

PRAH

0.00%

165.21

Gilead Sciences Inc

GILD

+1.02%

123.00

Arcturus Therape

ARCT

+2.51%

7.76

Incyte Corp

INCY

+1.79%

105.28

Aptevo Therapeutics Inc

APVO

+0.79%

8.95

Biospecifics

BSTC

0.00%

88.53

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.